The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Role of the F-box protein Skp2 in lymphomagenesis
Open accessAbstract
The F-box protein Skp2 (S-phase kinase-associated protein 2) positively regulates the G 1-S transition by controlling the stability of several G 1 regulators, such as the cell cycle inhibitor p27. We show here that Skp2 expression correlates directly with grade of malignancy and inversely with p27 levels in human lymphomas. To directly evaluate the potential of Skp2 to deregulate growth in vivo, we generated transgenic mice expressing Skp2 targeted to the T-lymphoid lineage as well as double transgenic mice coexpressing Skp2 and activated N-Ras. A strong cooperative effect between these two transgenes induced T cell lymphomas with shorter latency and higher penetrance, leading to significantly decreased survival when compared with control and single transgenic animals. Furthermore, lymphomas of Nras single transgenic animals often expressed higher levels of endogenous Skp2 than tumors of double transgenic mice. This study provides evidence of a role for an F-box protein in oncogenesis and establishes SKP2 as a protooncogene causally involved in the pathogenesis of lymphomas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
Carrano, A. C., Eytan, E., Hershko, A., & Pagano, M. (1999) · Nature Cell Biology · doi:10.1038/12013 · Cited by 1,543
Self-citationBai, C., Sen, P., Hofmann, K., Ma, L., Goebl, M., Harper, J. W., & Elledge, S. J. (1996) · Cell · doi:10.1016/s0092-8674(00)80098-7 · Cited by 1,415
SCF and Cullin/RING H2-Based Ubiquitin Ligases
Deshaies, R. J. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.435 · Cited by 1,242
Loda, M., Cukor, B., Tam, S. W., Lavin, P., Fiorentinc, M., Draetta, G. F., Jessup, J. M., & Pagano, M. (1997) · Nature Medicine · doi:10.1038/nm0297-231 · Cited by 1,031
Self-citationKipreos, E. T., & Pagano, M. (2000) · Genome biology · doi:10.1186/gb-2000-1-5-reviews3002 · Cited by 852
Self-citationTsvetkov, L. M., Yeh, K.-H., Lee, S.-J., Sun, H., & Zhang, H. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80290-5 · Cited by 791
Nakayama, K. (2000) · The EMBO Journal · doi:10.1093/emboj/19.9.2069 · Cited by 717
p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells
Sutterlüty, H., Chatelain, E., Marti, A., Wirbelauer, C., Senften, M., Müller, U., & Krek, W. (1999) · Nature Cell Biology · doi:10.1038/12027 · Cited by 700
Regulation of the Cdk inhibitor p27 and its deregulation in cancer
Slingerland, J., & Pagano, M. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200004)183:1<10::aid-jcp2>3.0.co;2-i · Cited by 695
Self-citationInsights into SCF ubiquitin ligases from the structure of the Skp1–Skp2 complex
Schulman, B. A., Carrano, A. C., Jeffrey, P. D., Bowen, Z., Kinnucan, E. R. E., Finnin, M. S., Elledge, S. J., Harper, J. W., Pagano, M., & Pavletich, N. P. (2000) · Nature · doi:10.1038/35042620 · Cited by 608
Self-citationUbiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation
Montagnoli, A., Fiore, F., Eytan, E., Carrano, A. C., Draetta, G. F., Hershko, A., & Pagano, M. (1999) · Genes & Development · doi:10.1101/gad.13.9.1181 · Cited by 597
Self-citationCombinatorial control in ubiquitin-dependent proteolysis: don't Skp the F-box hypothesis
Patton, E. (1998) · Trends in Genetics · doi:10.1016/s0168-9525(98)01473-5 · Cited by 500
pl9skp1 and p45skp2 are essential elements of the cyclin A-CDK2 S phase kinase
Zhang, H., Kobayashi, R., Galaktionov, K., & Beach, D. (1995) · Cell · doi:10.1016/0092-8674(95)90271-6 · Cited by 459
Latres, E., Chiaur, D. S., & Pagano, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202653 · Cited by 443
Self-citationBodrug, S. E., Warner, B. J., Bath, M. L., Lindeman, G. J., Harris, A. W., & Adams, J. M. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06488.x · Cited by 441
Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21 CIP1/WAF1 and cyclin D proteins
Yu, Z.-K., Gervais, J. L. M., & Zhang, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.19.11324 · Cited by 411
Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice.
Lovec, H., Grzeschiczek, A., Kowalski, M. B., & Möröy, T. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06655.x · Cited by 410
Identification of a family of human F-box proteins
Cenciarelli, C., Chiaur, D. S., Guardavaccaro, D., Parks, W., Vidal, M., & Pagano, M. (1999) · Current Biology · doi:10.1016/s0960-9822(00)80020-2 · Cited by 367
Self-citationA family of mammalian F-box proteins
Winston, J. T., Koepp, D. M., Zhu, C., Elledge, S. J., & Harper, J. W. (1999) · Current Biology · doi:10.1016/s0960-9822(00)80021-4 · Cited by 357
Marti, A., Wirbelauer, C., Scheffner, M., & Krek, W. (1999) · Nature Cell Biology · doi:10.1038/8984 · Cited by 318
Gerdes, J. (1990) · PubMed · Cited by 300
Chiarle, R., Budel, L. M., Skolnik, J., Frizzera, G., Chilosi, M., Corato, A., Pizzolo, G., Magidson, J., Montagnoli, A., Pagano, M., et al. (2000) · Blood · doi:10.1182/blood.v95.2.619 · Cited by 216
Self-citationNguyen, H., Gitig, D. M., & Koff, A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1190 · Cited by 158
Chiarle, R., Podda, A., Prolla, G., Podack, E. R., Thorbecke, G. J., & Inghirami, G. G. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.1.194 · Cited by 110
Self-citationGroth, A., Weber, J. D., Willumsen, B. M., Sherr, C. J., & Roussel, M. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003417200 · Cited by 102
Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector
Adams, J. M., Harris, A. W., Strasser, A., Ogilvy, S., & Cory, S. (1999) · Oncogene · doi:10.1038/sj.onc.1202997 · Cited by 89
Mangues, R., Symmans, W. F., Lu, S., Schwartz, S., & Pellicer, À. (1996) · PubMed · Cited by 33
Mangues, R., Schwartz, S., Seidman, I., & Pellicer, À. (1995) · Molecular Carcinogenesis · doi:10.1002/mc.2940140205 · Cited by 9
Cited by
Structure of the Cul1–Rbx1–Skp1–F boxSkp2 SCF ubiquitin ligase complex
Zheng, N., Schulman, B. A., Song, L., Miller, J. J., Jeffrey, P. D., Wang, P., Chu, C., Koepp, D. M., Elledge, S. J., Pagano, M., et al. (2002) · Nature · doi:10.1038/416703a · Cited by 1,507
Self-citationTo cycle or not to cycle: a critical decision in cancer
Malumbres, M., & Barbacid, M. (2001) · Nature Reviews Cancer · doi:10.1038/35106065 · Cited by 1,468
Ubiquitin ligases: cell-cycle control and cancer
Nakayama, K. I., & Nakayama, K. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1881 · Cited by 1,433
The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy
Chu, I. M., Hengst, L., & Slingerland, J. M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2347 · Cited by 990
Welcker, M., Orian, A., Jin, J., Grim, J. A., Harper, J. W., Eisenman, R. N., & Clurman, B. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402770101 · Cited by 941
Metadata
- Authors
- Latres, E., Chiarle, R., Schulman, B. A., Pavletich, N. P., Pellicer, A., Inghirami, G., & Pagano, M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2001-02-20
- Volume
- 98
- Issue
- 5
- Pages
- 2515-2520
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2011466019
- Cited by
- 279
- References
- 28
- FWCI
- 12.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.